Luma Health raises $6 million for messaging software, the Department of Energy pursues AI for suicide and prostate cancer prevention, and Philip Roth dies.
After a year as HHS' chief technology officer, Bruce Greenstein will leave the agency to join home health provider LHC Group.
Ninety-one percent of nearly 250 emergency physicians surveyed in a new ACEP poll said they had experienced a shortage or absence of critical medicine in their emergency department in the past month. That increases costs and compromises care.
The Government Accountability Office urged the CMS to continue several experiments that require providers and medical equipment suppliers to prove they are meeting certain standards before being paid, as that could save the agency billions.
The justices ruled 5-4 that employers can prohibit their employees from turning to class-action litigation to resolve workplace disputes.
Morris & Dickson can start distributing opioids again, privacy advocates worry about AI transcription services, and investigators turn to public geneaology to identify a murder suspect.
As consumer tech companies enter the healthcare market, health systems find that consumerism is driving innovation.
In laying out the Trump administration's strategy for reducing drug prices, HHS Secretary Alex Azar suggested pumping up Medicare Part D by moving some expensive drugs out of Part B.
On May 25, regulators will start enforcing the GDPR. Here's what every healthcare organization should know.
FDA approves first migraine prevention drug, the FCC wants to increase funding for the Rural Health Care Program and the FDA drags its feet on the Impossible Burger.
The Veterans Affairs Department is moving onto software made by the same company that makes the Defense Department's EHR, which could be both a good and a bad thing.
The FDA claimed 39 drug companies may be blocking generic-drug makers from obtaining samples of their branded products to hinder generic competition.